SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006295
Filing Date
2018-08-03
Accepted
2018-08-03 08:16:11
Documents
70
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acrs-20180630x10q.htm 10-Q 2058004
2 EX-10.1 acrs-20180630ex1010d3fdd.htm EX-10.1 730028
3 EX-10.2 acrs-20180630ex10295c5c4.htm EX-10.2 22501
4 EX-31.1 acrs-20180630ex311dbaf13.htm EX-31.1 17118
5 EX-31.2 acrs-20180630ex312de6af5.htm EX-31.2 17104
6 EX-32.1 acrs-20180630ex321b66186.htm EX-32.1 10651
  Complete submission text file 0001558370-18-006295.txt   8627940

Data Files

Seq Description Document Type Size
7 EX-101.INS acrs-20180630.xml EX-101.INS 1928822
8 EX-101.SCH acrs-20180630.xsd EX-101.SCH 42790
9 EX-101.CAL acrs-20180630_cal.xml EX-101.CAL 53315
10 EX-101.DEF acrs-20180630_def.xml EX-101.DEF 156300
11 EX-101.LAB acrs-20180630_lab.xml EX-101.LAB 466487
12 EX-101.PRE acrs-20180630_pre.xml EX-101.PRE 313618
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37581 | Film No.: 18990369
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1